Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oceania HealthcareASX:OCA 41 EV-to-EBITDA is 24.20 as of Jul. 31, 2026, which is 88% above its 10-year median of 12.88. GuruFocus rates ASX:OCA with a GF Score™ of 41/100 and a GF Value™ of A$0.71 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Oceania Healthcare ranks worse than 82.32% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Oceania Healthcare's enterprise value is A$867.2 Mil.
Oceania Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was A$35.8 Mil. Therefore, Oceania Healthcare's EV-to-EBITDA for today is 24.20.
The historical rank and industry rank for Oceania Healthcare's EV-to-EBITDA or its related term are showing as below:
ASX:OCA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -151.69 Med: 12.88 Max: 26.06
Current: 25.44
During the past 9 years, the highest EV-to-EBITDA of Oceania Healthcare was 26.06. The lowest was -151.69. And the median was 12.88.
ASX:OCA's EV-to-EBITDA is ranked worse than 82.32% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.04
vs ASX:OCA: 25.44
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Oceania Healthcare's PE Ratio (TTM) for today is calculated as:
Oceania Healthcare's share price for today is A$0.62.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oceania Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was A$0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Oceania Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Oceania Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oceania Healthcare EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oceania Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Oceania Healthcare's EV-to-EBITDA falls into.
Oceania Healthcare's current Enterprise Value is A$867.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oceania Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was A$35.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oceania Healthcare (ASX:OCA) has a EV-to-EBITDA of 24.20 as of Jul. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Oceania Healthcare. This is 88% above median its historical median of 12.88. According to the industry distribution chart, Oceania Healthcare ranks #419 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 82.3%.
Is Oceania Healthcare's EV-to-EBITDA too high?
Oceania Healthcare's current EV-to-EBITDA of 24.20 is 88% above median its 10-year median of 12.88. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.04. Oceania Healthcare's value of 24.20 is 119.2% above this industry median. Based on the distribution chart, Oceania Healthcare ranks #419 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Oceania Healthcare has a GF Score™ of 41/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oceania Healthcare's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Oceania Healthcare ranks #419 out of 509 companies for EV-to-EBITDA. This places Oceania Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 11.04. Oceania Healthcare's value of 24.20 is 119.2% above this benchmark. While the company's 10-year median is 12.88 vs. the industry median of 11.04, Oceania Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.04, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oceania Healthcare's current EV-to-EBITDA of 24.20 is 119.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Oceania Healthcare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oceania Healthcare's current EV-to-EBITDA is 24.20, which is 88% above median its own 10-year median of 12.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oceania Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oceania Healthcare (ASX:OCA) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.71, compared to a current price of A$0.62 — trading 12.7% below its estimated fair value. The current EV-to-EBITDA is 24.20, which is 88% above median its 10-year median of 12.88 and 119.2% above the Healthcare Providers & Services industry median of 11.04. Oceania Healthcare's overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Oceania Healthcare (ASX:OCA), the current EV-to-EBITDA is 24.20 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oceania Healthcare (ASX:OCA) Overvalued in 2026?
Based on GuruFocus' analysis, Oceania Healthcare stock appears to be undervalued.
The current stock price of A$0.62 is trading 12.7% below its estimated GF Value™ of A$0.71.
GuruFocus considers Oceania Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:OCA:
EV-to-EBITDA: 24.20 (88% above median its 10-year median of 12.88)
GF Value™: A$0.71 vs. price of A$0.62 (12.7% below fair value)
Industry Position: 119.2% above the Healthcare Providers & Services median (#419 of 509)
No single metric tells the full story. See the ASX:OCA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oceania Healthcare Ltd owns and operates rest homes and retirement villages. The business activities of the group are operated through care operations, village operations, and other segments. The company generates maximum revenue from the care operations segment, which includes traditional care beds and care suites as well as the provision of accommodation, care, care packages, meals, and related services to aged care residents. Geographically, it operates throughout New Zealand. The company derives revenue from Rest homes, hospitals, dementia fees, and others.
41GF Score
Get the complete analysis for ASX:OCA
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:OCA has been successfully added to your 
